Funder: American Cancer Society
Due Dates: June 1, 2026 | December 1, 2026
Funding Amounts: Stage I: Up to $135,000/year (2 years max) plus 10% indirect, total $297,000; Stage II: Up to $545,000 (18 months) plus 10% indirect
Summary: Supports innovative cancer research projects focused on translating discoveries to human testing, with two-stage funding for clinical-enabling work.
Key Information: Applicants may only submit one MBG application per cycle and cannot submit RSG, DBG, or CSDG in the same cycle.